News

Cardiff University Bioinformatics programme shortlisted in the Wales STEM Awards 2022

4 October 2022

The Bioinformatics MSc programme based within the School of Medicine is amongst the prestigious businesses and individuals shortlisted in the 2022 Wales STEM Awards.

Dr Martin Scurr, Prof Andrew Godkin, Dr James Hindley, Cardiff University / ImmunoServ Ltd.

Finger-prick blood test identifies immunity to COVID-19

22 September 2022

Measuring T cells shows risk of reinfection

Project Sepsis to hold Sepsis in the Digital Age webinar to mark World Sepsis Day 2022

30 August 2022

University researchers to hold virtual event to raise awareness of sepsis and the digital technology that could help to diagnose and treat the condition.

Cardiff University medical student selected for prestigious scholarship

16 August 2022

Fourth-year student Chantal Corbin will join Healthcare Leadership Academy programme

Study pinpoints SARS-CoV-2 Spike mutation that ‘escapes’ killer T-cells generated by infection and vaccination

5 August 2022

Cardiff University scientists urge monitoring of ‘viral escape’ – and warn vaccines may need altering

Impact of research and teaching showcased at National Eisteddfod

28 July 2022

Events will examine topics including children’s rights, politics, science and history

Medicine graduate who taught herself A-level science urges other students to pursue dreams

20 July 2022

Cardiff University student Sophie Hulse studied Medicine via graduate entry scheme

SARS-CoV-2-infected cells (cell nucleus in blue, cell surface in green and viral proteins in red)

Scientists shed new light on how SARS-CoV-2 evades the immune response in early infection

19 July 2022

New study could have implications for vaccine design

Cardiff University researchers to join £20m global study to tackle cancer in children

16 June 2022

Professor Andrew Sewell and team win funding from Cancer Grand Challenge

UK researchers pioneer new virtual treatment for PTSD

15 June 2022

Online treatment ‘as effective as face-to-face therapy’, large-scale clinical trial finds